NEOGENOMICS INC — Director's Dealing 2015

May 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2015-05-04

Reporting Person: ROSS STEVEN A (CIO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-04	Stock Options (Right to Buy)	$4.78	A	100000	Acquired	2020-05-05	Common Stock (100000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4500	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to buy)	$3.93	2019-04-22	Common Stock (150000)	150000	Direct

Footnotes

F1: On May 4, 2015 Mr. Ross was granted 100,000 stock options to purchase Common Stock of the Company. These options vest ratably on each of the first three anniversary dates from the date of grant.

F2: On April 22, 2013 Mr. Ross was granted 150,000 stock options to purchase common stock in the Company. These options vest ratably on each of the next 4 anniversary dates from the date of grant.